Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 11 studies | 34% ± 16% | |
endothelial cell | 11 studies | 25% ± 12% | |
astrocyte | 11 studies | 30% ± 13% | |
oligodendrocyte precursor cell | 9 studies | 34% ± 16% | |
adipocyte | 7 studies | 22% ± 5% | |
fibroblast | 7 studies | 26% ± 11% | |
GABAergic neuron | 6 studies | 37% ± 14% | |
epithelial cell | 6 studies | 32% ± 14% | |
ciliated cell | 6 studies | 27% ± 10% | |
myeloid cell | 5 studies | 19% ± 3% | |
endothelial cell of lymphatic vessel | 5 studies | 25% ± 6% | |
microglial cell | 5 studies | 27% ± 7% | |
macrophage | 5 studies | 29% ± 9% | |
interneuron | 5 studies | 42% ± 21% | |
lymphocyte | 4 studies | 22% ± 5% | |
retinal cone cell | 4 studies | 25% ± 6% | |
retina horizontal cell | 4 studies | 21% ± 5% | |
glutamatergic neuron | 4 studies | 44% ± 21% | |
pericyte | 4 studies | 25% ± 9% | |
T cell | 3 studies | 18% ± 1% | |
hematopoietic precursor cell | 3 studies | 24% ± 6% | |
abnormal cell | 3 studies | 31% ± 11% | |
basal cell | 3 studies | 33% ± 16% | |
myofibroblast cell | 3 studies | 21% ± 6% | |
smooth muscle cell | 3 studies | 20% ± 1% | |
transit amplifying cell | 3 studies | 36% ± 23% | |
neuron | 3 studies | 39% ± 17% | |
mast cell | 3 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2771.48 | 1444 / 1445 | 100% | 15.19 | 183 / 183 |
lung | 100% | 3034.22 | 578 / 578 | 100% | 12.34 | 1151 / 1155 |
breast | 100% | 3168.91 | 459 / 459 | 100% | 15.64 | 1114 / 1118 |
uterus | 100% | 3985.24 | 170 / 170 | 100% | 15.48 | 457 / 459 |
bladder | 100% | 2898.95 | 21 / 21 | 99% | 14.62 | 501 / 504 |
brain | 99% | 2141.65 | 2619 / 2642 | 100% | 24.14 | 705 / 705 |
pancreas | 100% | 1879.58 | 328 / 328 | 99% | 11.49 | 176 / 178 |
thymus | 100% | 3939.23 | 653 / 653 | 99% | 14.10 | 598 / 605 |
ovary | 100% | 5533.03 | 180 / 180 | 99% | 9.45 | 425 / 430 |
prostate | 100% | 3571.26 | 245 / 245 | 99% | 10.83 | 496 / 502 |
intestine | 100% | 3410.20 | 966 / 966 | 98% | 12.46 | 516 / 527 |
stomach | 100% | 2180.25 | 359 / 359 | 98% | 12.76 | 279 / 286 |
adrenal gland | 100% | 2266.09 | 258 / 258 | 96% | 8.35 | 221 / 230 |
kidney | 100% | 2280.08 | 89 / 89 | 92% | 10.16 | 827 / 901 |
skin | 100% | 2755.26 | 1809 / 1809 | 91% | 10.92 | 429 / 472 |
liver | 100% | 1763.36 | 226 / 226 | 81% | 5.74 | 329 / 406 |
adipose | 100% | 2791.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 3455.01 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.09 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.24 | 1 / 1 |
blood vessel | 100% | 2269.77 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1569.71 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1475.12 | 844 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 10.51 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 61% | 5.48 | 49 / 80 |
peripheral blood | 57% | 1124.76 | 529 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0014842 | Biological process | regulation of skeletal muscle satellite cell proliferation |
GO_2000288 | Biological process | positive regulation of myoblast proliferation |
GO_0007517 | Biological process | muscle organ development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_1990226 | Molecular function | histone methyltransferase binding |
Gene name | PAXBP1 |
Protein name | PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1) PAX3 and PAX7 binding protein 1 |
Synonyms | C21orf66 GCFC1 GCFC |
Description | FUNCTION: Adapter protein linking the transcription factors PAX3 and PAX7 to the histone methylation machinery and involved in myogenesis. Associates with a histone methyltransferase complex that specifically mediates dimethylation and trimethylation of 'Lys-4' of histone H3. Mediates the recruitment of that complex to the transcription factors PAX3 and PAX7 on chromatin to regulate the expression of genes involved in muscle progenitor cells proliferation including ID3 and CDC20 (By similarity). . |
Accessions | ENST00000421049.1 ENST00000445049.1 Q9Y5B6 ENST00000331923.9 [Q9Y5B6-1] ENST00000290178.4 [Q9Y5B6-2] H7C2W4 ENST00000573680.5 ENST00000574159.2 H7BZC8 ENST00000443785.5 [Q9Y5B6-4] |